Medically tailored meals lower HbA1c more than food subsidies in type 2 diabetes
A randomized clinical trial presented at the 2026 American Diabetes Association Scientific Sessions revealed that food-insecure adults with type 2 diabetes who received home-delivered medically tailored meals and lifestyle counseling for six months achieved significantly lower HbA1c levels compared to those given a monthly food subsidy. The study emphasized that the specialized oversight of a registered dietitian, who tailored the meals to individual comorbidities and preferences, was a critical factor in achieving superior glycemic control.
HNH Insight
This trial provides robust evidence that the 'clinical' component of medically tailored meals—personalized design by a registered dietitian—is a primary driver of its therapeutic efficacy compared to standard financial food assistance. For healthcare payers, this suggests that the higher cost of MTM is justified by measurable clinical improvements in high-risk patients that generic subsidies fail to match.
Exchange Discussion
Join the expert conversation on this article in the HN&H Intelligence Exchange. Professional discussion only — cite your sources.
No comments yet.
